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Abstract
Clinical methods that assess gait in Parkinson’s Disease (PD)
are mostly qualitative. Quantitative methods necessitate costly
instrumentation or cumbersome wearable devices, which lim-
its their usability. Only few of these methods can discriminate
different stages in PD progression. This study applies machine
learning methods to discriminate six stages of PD. The data
was acquired by low cost walker-mounted sensors in an ex-
periment at a movement disorders clinic and the PD stages
were clinically labeled. A large set of features, some unique
to this study are extracted and three feature selection methods
are compared using a multi-class Random Forest (RF) classi-
fier. The feature subset selected by the Analysis of Variance
(ANOVA) method provided performance similar to the full
feature set: 93% accuracy and had significantly shorter com-
putation time. Compared to PCA, this method also enabled
clinical interpretability of the selected features, an essential
attribute to healthcare applications. All selected-feature sets
are dominated by information theoretic features and statistical
features and offer insights into the characteristics of gait dete-
rioration in PD. The results indicate a feasibility of machine
learning to accurately classify PD severity stages from kine-
matic signals acquired by low-cost, walker-mounted sensors
and implies a potential to aid medical practitioners in the quan-
titative assessment of PD progression. The study presents a
solution to the small and noisy data problem, which is common
in most sensor-based healthcare assessments.
Introduction
Automated disease diagnosis has the potential to reduce la-
bor and cost in healthcare, as well as offer an augmented
accuracy which may improve treatment efficacy. Machine
learning methods that could provide automated disease as-
sessment have been extensively studied on medical imaging
and physiological signals datasets.
These studies reported accurate detection of diseases and
dysfunctions such as cardiovascular disease (Poplin et al.
2018), kidney dysfunction (Tomašev et al. 2019), brain tu-
mors (Havaei et al. 2017) and more. When deep learning
methods are employed, very large datasets were needed, how-
ever, to provide accurate detection or classification of dis-
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eases. Such datasets are not available in many healthcare
contexts.
For patients suffering from Parkinson’s disease; a debili-
tating neuro-degenerative disease with increasing prevalence;
datasets are typically scarce and small. Parkinson’s disease
severity determination is predominantly based on observa-
tional or reported symptoms which are challenging to reliably
acquire in an automated manner. Healthcare professionals
and patients could greatly benefit from automated disease
assessment tools since observation- or reporting-based data
are qualitative and subjective, and hence are prone to bias
and inaccuracy, which may lead to incorrect treatment.
Attempts to automate Parkinson’s disease assessment typi-
cally use sensors that capture patients’ motor data (Jarchi et
al. 2018). Although sensors have the potential to efficiently
record large quantities of quantitative and objective data, prac-
tical considerations often limit their usage in clinical settings:
Many sensors and devices are cumbersome and uncomfort-
able, and/or are not suitable for severe stages of Parkinson’s
disease, when patients cannot walk without support (Aharon-
son et al. 2018; Bryant et al. 2014). The small data size may
also be the reason that the goal in most previous works was
to discriminate between patients and controls, without at-
tempting the multi-class discrimination of disease stages. An
accurate and timely discrimination of disease progression
stages is very important for efficient treatment and patient
care.
This paper makes the following contributions:
• A novel sensor-based system that offers a solution to
the aforementioned limitations. This system collects ad-
equate data on Parkinson’s disease symptoms and uses
machine learning for quantitative multi-class discrimina-
tion of Parkinson’s disease stages.
• A machine learning method that can provide in a translu-
cent way the most relevant features that discriminate be-
tween Parkinson’s disease stages. This method enables
non-technological healthcare professionals to interpret the
system’s output and employ their interpretation in patient-
care planning
• Solutions for the application of machine learning on small-
scale datasets of noisy sensors’ signals through an integra-
tion of signal processing techniques.
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Figure 1: System Pipeline outlining the six stages of processing from raw data acquired from the instrumented walker till the
classification stage of PD stage.
Background and Related Work
Parkinson’s Disease
Parkinson’s disease (PD) affects more than 10 million indi-
viduals globally (de Lau and Breteler 2006). This debilitat-
ing neuro-degenerative disease manifests in both physical
and mental symptoms (Perumal and Sankar 2016; Sayeed
2015). Many of the physical symptoms pertain to gait; the
manner in which a person walks (Perumal and Sankar 2016;
Sayeed 2015).
Gait impairments reduces mobility, significantly limits a
person’s functionality and independence and can cause in-
stability and fall hazards. Thus, the assessment of gait is an
important component in discriminating the severity of Parkin-
son’s disease (Chen et al. 2013; Dingwell and Cusumano
2000).
The Hoehn and Yahr scale is commonly employed by
clinicians to reflect Parkinson’s disease severity, providing
severity stages between 1 and 5 (Hoehn and Yahr 1998). As
an extension to the integer severity scale, the modified Hoehn
and Yahr scale has included a “mid-stage” of 2.5, in order to
add granularity and reduce uncertainty in the discrimination
(Goetz et al. 2004).
The Hoehn and Yahr scale particularly pertains to gait and
postural stability (Hoehn and Yahr 1998). While this scale is
validated and has a standardized assessment procedure, the
evaluation of the symptoms that provide its scores entails a
subjective component (Wang 2014). This affects the accuracy
and objectivity of the diagnosis and hampers patient care.
Moreover, the assessment is time-consuming and necessi-
tates expert neurologists, which poses a burden on resource
constrained healthcare settings and has limited accessibility
to patients.
The Timed-Up-and-Go (TUG) test, is sometimes used in
addition to the Hoehn and Yahr assessment (Aharonson et
al. 2018; Sprint, Cook, and L Weeks 2015; Yahalom et al.
2018). This test is simple, short and focuses only on gait:
A patient sitting on a chair is requested to stand up, walk
straight forward for 3m, turn around, walk back and sit on
the chair, and the task completion time is logged.
This method, however, only provides a single, rough mea-
sure that does not properly characterize the impairments en-
tailed in the compound movement of the test. Furthermore,
this method still necessitates human observation and manual
handling of a stopwatch or button, which limits its accuracy
(Aharonson et al. 2018; Sprint, Cook, and L Weeks 2015;
Yahalom et al. 2018).
Quantitative Methods
Automated assessments combining machine learning and
sensor-based data acquisition are a potential solution to the
aforementioned limitations of Parkinson’s disease assess-
ments.
In previous studies, sensors such as accelerometers and
gyroscopes, were of the strap-on or wearable type (Mariani
2012; Salarian et al. 2004; Yahalom et al. 2018). Moving
with the patient’s body, these sensors were able to capture
kinematic data of the patient’s gait.
Although low-cost, most of these sensors are complex to
strap on or wear and therefore are time-consuming to use for
healthcare professionals, patients or caregivers. Additionally,
some of these devices are cumbersome and uncomfortable
to wear, thereby harming the user experience, especially for
motor impaired persons (Aharonson et al. 2018).
Moreover, in more severe cases of Parkinson’s disease,
patients require a walking aid such as a walker or cane, which
further limits the usability and accuracy of wearables (Bryant
et al. 2014).
That being said, previous studies of sensors acquiring kine-
matic signals coupled with machine learning reported impres-
sive algorithmic accuracy when discriminating two classes:
patients from controls, or a when detecting a specific symp-
tom.
Accelerometers placed on different parts of the body and a
neural network classifier were able to discriminate between
the presence or absence of dyskinesia in PD patients with an
accuracy of 96.7% (Keijsers, Horstink, and Gielen 2003).
Smartphone accelerometer data and a random forest clas-
sifier yielded a discrimination of PD patients from controls
with a sensitivity of 96.2% and specificity of 96.9% (Arora
et al. 2015).
Infrared sensors used with a neural network classifier and
a Support Vector Machine (SVM) discriminated PD patients
from controls with an accuracy of 98% and 100%, respec-
tively (Tahir and Manap 2012).
To the best of our knowledge, no full sensor-based solution
for sensor-based data acquisition overcoming the aforemen-
tioned usability limitations has been proposed, and no studies
attempted a sensor-based classification of Hoehn and Yahr
severity stages of PD.
Our Approach: Machine learning to enable
Parkinson’s Disease stage discrimination from
low-cost walker mounted sensor data
We present a novel solution where machine learning is used
for Parkinson’s disease stage discrimination, as labelled by
the modified Hoehn and Yahr severity scale.
The solution includes kinematic signals acquisition by
walker-mounted sensors. The walker method provides a
patient-centric approach that combines reliability and us-
ability, even for severe stages of the disease.
The solution includes techniques that can provide an accu-
rate discrimination for small datasets, and for noisy signals,
conditions that are typical to many healthcare datasets.
Finally, our solution provides listing and ranking of ex-
plicable features in terms of their contribution to PD stage
discrimination, which can readily be interpreted and used by
clinicians for decision making in their patients assessment
and treatment.
The analysis pipeline outlined in Figure 1 is implemented
as follows:
Dataset
The data used in this study was acquired by a low-cost alu-
minum walking frame retrofitted with low-cost and off-the-
shelf kinematic sensors. The usage of a walking frame allows
the subject’s gait to be monitored unobtrusively, whilst simul-
taneously supporting walking.
The latter trait of supporting the subject is particularly
important in advanced stages of the disease, when a walker
is necessary for mobility.
The sensors include a tri-axial accelerometer, distance
encoders on the wheels, and force sensors on the handles that
measure grip strength.
The data acquired consists of the following seven signals:
• two force signals
• two distance encoder signals
• three acceleration signals (x,y,z axis)
Sixty-seven PD patients and nineteen age-matched healthy
controls were subjected to the timed up and go (TUG) tests
while using the walker.
PD severity scores were assigned using the modified
Hoehn and Yahr severity scores of 1, 2, 2.5, 3 and 4. Hoehn
and Yahr scores of 5 were not included as these patients are
bed ridden or confined to a wheelchair without assistance
and are unable to perform the walking test (Hoehn and Yahr
1998).
The Hoehn and Yahr stage was determined during a routine
clinical assessment by a movement disorders neurologist.
The study was conducted in a Movement Disorders Insti-
tute of a tertiary Medical Center. It was approved by the local
institutional review board and all subjects signed an informed
consent.
Data pre-processing
Pre-processing can enhance the reliability of feature extrac-
tion and is particularly important when the data acquired is
small in size. Small data size is common in experimental data
acquisition where busy clinic conditions and patient recruit-
ment challenges preclude large number of measurements.
Pre-processing is necessary for most sensors’ data, and
particularly in the case of low-cost sensors, that often entail
noisy, less accurate output. In our specific case of walker-
mounted sensors, where the sensors do not move with the
subject’s body, a tailored pre-processing is needed in order
to correctly detect footfalls – the basic elements of gait.
The pre-processing of the walker’s signals include noise
and artifact removal, footfall detection, and segmentation of
the walking phases into straight-line walking and turning
phases: All the signals are denoised using a zero-phase lag
moving average filter, thereby mitigating phase distortion.
A Rodriquez Rotation matrix is employed to rotate the
accelerometer signal and align it with the direction of subject
movement.
An adaptive Empirical Mode Decomposition (EMD) algo-
rithm is then applied to the accelerometer signals in order to
further denoise these signals for the footfall detection algo-
rithm.
Our novel footfall detection algorithm is applied and vali-
dated using video-camera manually-labeled data. Our algo-
rithm yields an accuracy of 86%, a significant improvement
over a previous walker-based footfall detection algorithm
from (Ballesteros et al. 2017).
Feature extraction
The extracted feature set provides a quantitative represen-
tation of a subject’s gait and are an amalgamation of novel
features pertinent to the system used in this study and features
widely used in previous studies.
However, the derivation of the latter features need to be
adjusted for the signals of the walker-mounted sensor system,
where sensor type, quality and placement are different from
previous studies.
In total 211 features are extracted across four broad cat-
egories: spatio-temporal features, statistical features, fre-
quency domain features and information theoretic features;
1. Spatio-temporal features (which quantify the characteris-
tics used by clinicians in their assessments of gait), such as
step length, Timed-Up-and-Go (TUG) walk time, number
of steps and turn time.
2. Statistical Features, such as skewness, kurtosis, measures
of central tendency, quartiles, mean and standard deviation
of the signals’ segments.
3. Frequency Domain Features such as mean frequency,
3dB bandwidth, 99% occupied bandwidth, 99% occupied
power, half power.
4. Information Theoretic Features such as cross-entropy, mu-
tual information between axis, correlation between axes,
walk ratio, walking intensity, harmonic ratio, zero cross
rate.
All accelerometer features are computed for the 3-axis of
the accelerometer (the Cartesian x,y and z) as well as for their
spherical co-ordinates: azimuth angle, elevation (polar) angle
and radial distance.
Feature selection
The small data size requires feature selection to reduce di-
mensionality for the initial high- dimensional feature space
of 211 features.
The selection can also convey information on the type or
categories of features which capture the characteristics of the
phenomena studied. This trait is very important for clinical
usage and research of the disease.
Three methods of feature selection are examined in this
study:
Principal Components Analysis (PCA)
PCA is applied, and the principal components which
explained 95% of the variance are chosen. PCA is a widely
used feature selection method, and was used in previous
studies on PD gait.
However, a major drawback of this method in healthcare
contexts is that the selected feature set contains linear com-
binations of features. The resulting transformed features can
no longer be easily interpreted by clinicians.
This is especially relevant as a particular focus in the se-
lection process is to determine the most important features
in terms of discrimination between the different Parkinson’s
disease stages, as determined by the Hoehn and Yahr scores.
This is not possible for the transformed PCA features. In
order to address this need, two additional selection methods,
that maintain the original features are implemented.
Feature Selection using ANOVA
The one-way ANOVA test is performed on each fea-
ture, to search for significant statistical difference, of p-value
of smaller than 0.05, between the means of three or more
from the different Hoehn and Yahr groups. The features that
reject the Null Hypothesis (no difference) are then selected.
Embedded Feature Selection: Random Forest
The embedded feature selection of the random forest
ensemble classifier provides the features which are deter-
mined as important for the classification. The "important
features" set implementation in this study consists of
the features that are determined by the random forest as
important in 80% of the trials. The test of feature importance
is repeated 5 times.
Classification
A Random Forest (RF) classifier (Breiman 2001) is imple-
mented to discriminate the different Hoehn and Yahr scores.
This classifier is chosen based on two important properties
for the sought discrimination: The ensemble nature of the
Random Forest algorithm is well suited to the small data
problem, unlike other more data hungry algorithms.
Secondly, the Random Forest allows feature importance
to be quantified in terms of their discrimination power. This
trait is particularly relevant from the medical interpretability
perspective, where the features are considered within the clin-
ical severity classification. The classifier’s hyper-parameters
are optimized and tested on the full feature set and for each
of the selected feature sets.
Experimental evaluation
The effectiveness of our method for automated discrimination
of Parkinson’s disease stages is evaluated according to two
criteria, where the latter criterion is particularly important for
clinical interpretability:
1. Discrimination accuracy and execution time
2. The amount of information gained on features and feature
categories relevance to this discrimination.
Classification accuracy is defined as the percentage of sub-
jects correctly classified based on the clinically determined
Hoehn and Yahr scores. Execution time is measured as a
complementing classification efficacy metric for real-world
clinical application.
These two metrics are computed for the full feature set and
for each of the three selected feature sets : ANOVA selected
features, Random Forest selected features and PCA derived
features.
Each feature set is classified by a Random Forest classifier
of 100 trees, split using the Gini co-efficient. To ensure a
fair comparison the number of trees is kept consistent for all
selected feature sets.
Table 1: Accuracy and full feature set and the three selected subsets in the classification of Hoehn and Yahr PD stages
TEST SET \PERFORMANCE MEASURE ACCURACY (%) MEAN EXECUTION TIME (S)
ALL FEATURES 94 ± 1.02 41.4
ANOVA SELECTED 93 ± 1.3 15.2
RF SELECTED 90 ± 1.7 6.36
PCA 95 ± 1.1 10.6
The hyper-parameter of the number of trees for the random
forest is tuned experimentally for varying numbers of trees
from 1-1000, where the selected number of trees provides
the best trade-off of accuracy and execution time.
Given the small data size problem, separate training, val-
idation and test sets are not possible for evaluation. Thus,
5-fold cross-validation is performed, where the data set is
randomly shuffled.
The important feature sets selected by the ANOVA and
Random Forest – the un-transformed feature sets – are then
compared and evaluated according to their relevance to dis-
crimination and clinical interpretability.
Discrimination metrics
The performance of the Random Forest classifier in discrim-
inating the six classes (Healthy controls and PD stages as
labelled by Hoehn and Yahr scale) is presented in Table 1.
Mean accuracy and its standard deviation, as well as mean
execution time are presented, for the four feature sets.
The dimensionality reduction of the feature space by the se-
lection methods was 78% for the PCA, 68% for the ANOVA
and 86% for the RF selection.
Figure 2 displays the confusion matrix for the Random
Forest classifier using the ANOVA selected features.
As illustrated by the values in the diagonal of the confusion
matrix in Figure 2, all healthy controls and Hoehn and Yahr 1,
3 and 4 are correctly classified. Mis-classification of 15.38%
and 11.1% is seen for Hoehn and Yahr 2 and 2.5 respectively.
The mis-classifications of these two labels are to a Hoehn
and Yahr stage lower (less severe) than the actual stage. The
overall mis-classification across all class labels was 6.98%.
Model interpretability and clinical implications
Only the ANOVA and RF selected features are untransformed
and can provide clinical interpretability.
Figure 3 portrays the feature categories, described in Sec-
tion 3.3 which are selected by the ANOVA and RF methods,
as well as the subset of features that are selected by both
selection methods.
Twenty six features are selected by both ANOVA and RF.
Their distribution according to feature categories is:
• spatio-temporal (4/26)
• frequency domain (2/26)
• information theoretic (9/26)
• statistical features (11/26)
Discussion
This study presents an automated and reliable machine learn-
ing method that provides discrimination of Parkinson’s dis-
ease stages using kinematic signals obtained from low cost
walker-mounted sensors.
The method includes signal pre-processing, feature ex-
traction methods and an extracted feature set which extend
previous studies (Aharonson et al. 2018; Akbari, Dewey, and
Jafari 2017; Ballesteros et al. 2017; Tahir and Manap 2012;
Jarchi et al. 2018) and overcome the challenges introduced
by low cost sensors and exo-body (walker) sensing of gait.
The results imply that the optimal configuration for this dis-
crimination consists of a reduced subset of ANOVA-selected
features, and a random forest classifier of 100 trees. The
mean accuracy achieved by this configuration is 93%.
The confusion matrix in Figure 2 indicates that classifi-
cation errors typically result in mis-classification into the
adjacent Parkinson’s disease stage (i.e. into the Hoehn and
Yahr stage immediately above or below the target stage).
Clinical literature indicates that diagnosis errors are more
frequent in stages 1 to 3, where patients are considered min-
imally disabled, and are still able to lead independent lives
(Scott et al. 1998). A modified Hoehn and Yahr that includes
“mid-stage” 2.5 is adopted by many clinicians in an attempt
to reduce the uncertainty in the discrimination of these stages,
by adding “resolution” to the scale (Goetz et al. 2004). The
scale containing “mid-scores” is, however, clinically contro-
versial.
In this study we use the stage 2.5 as a label and the results
indicate that all mis-classifications occur between the Hoehn
and Yahr stages 2 and 2.5. This may imply that the clinical
label of stage 2.5 is not a “mid-score” but rather is closer
to stage 2 than stage 3. The machine learning algorithm
proposed in this study may then be extended to provide a
finer stage division of the range 1 to 3 in the Hoehn and Yahr
scale.
The comparison of three feature selection methods as pre-
sented in Table 1 reveal that all three reduced feature sets
yielded a discrimination accuracy greater than 90% and of-
fered 3 to 5 times faster execution time.
The PCA selection method provides transformed features
output, which are not clinically interpretable: These feature
can no longer be individually identified and do not maintain
the units of the original features. This hinders the clinical
insight that can be obtained about the individual features’
manifestations in patient’s gait.
Between the ANOVA and RF selection methods, the
ANOVA is indicated as the best trade-off. Although slower
Figure 2: Confusion matrix of the Random Forest classifier using the ANOVA selected features. The horizontal axis indicates the
target Hoehn and Yahr class labels: healthy controls (HC) and stages 1, 2, 2,5, 3,and 4. The vertical axis similarly indicates the
output/predicted Hoehn and Yahr class labels.
than the RF selection, it still provides a 3-times faster execu-
tion time compared to the full set, while maintaining the orig-
inal set’s discrimination accuracy, and has higher accuracy
compared to the RF selection: 93%, and 90%, respectively.
The significantly lower discrimination accuracy of the ran-
dom forest-selected features may imply that for this data, the
internal feature selection performed in the random forest was
not able to select all of the relevant features to this multi-class
discrimination, when compared to PCA and ANOVA.
Extending previous studies that consider mainly spatio-
temporal features and/or provided binary discrimination of
patients from controls, the present study presents a multi-
class discrimination of healthy control subjects and five dif-
ferent PD severity stages. The performance put emphasis
on the importance of the features collected, in the context
of their contribution to the discrimination. Four categories
of features are evaluated by their prevalence in the machine
learning feature selection subsets.
The overlap, or common features that are selected by both
ANOVA and RF, is 87%. Interestingly, the small number of
features that are selected by ANOVA and not by the RF, has
contributed to a 3% higher discrimination accuracy.
Previous studies focused on spatio-temporal features and
specifically step time, step length and step velocity. Spatio-
temporal features like step length and step velocity are among
the significant features in our analysis, corroborating earlier
studies.
The current analysis extends previous studies by using sig-
nal processing and machine learning to extract a much wider
variety of features, divide them into four feature categories
and compare the implications of the different categories on
classification performance.
All selected subsets contain features from all four cate-
gories: spatio-temporal-, statistical-, frequency- and infor-
mation theory- based, implying that all are important for
Parkinson’s disease stage classification.
The percentage of information theory and statistical fea-
tures in all selected feature sets is much larger than the
spatio-temporal ones. This finding implies that gait analysis
of Parkinson’s disease should not be limited to the observ-
able, time-based features, but need also include these more
abstract and mathematical features. Including all four fea-
ture categories in the analysis may yield broader insight into
Parkinson’s disease gait deterioration with disease severity.
The analysis of feature importance and feature category
importance in our study may provide an insight for future
research into gait characteristics in Parkinson’s disease.
For example, the indication that the Hoehn and Yahr scale
is based on other motor assessments in addition to gait, but
could still be accurately classified using only gait features,
implies a significant impact of gait impairment characteristics
in the Hoehn and Yahr scale.
The combined usability design, signal processing and ma-
chine learning discrimination proposed in this study has the
potential to assist healthcare professionals in Parkinson’s dis-
ease severity evaluation and facilitate a patient-centred care
at a low-cost. The method is tested in a clinic, but has the
potential to be used in the future by patients at home enabling
quantitative PD severity assessment. This would be a step
towards integration into an eHealth monitoring scheme.
Figure 3: Selected features grouped by feature category for the ANOVA method, RF method and those features selected by both
ANOVA and RF
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